HealthAIdir logoHealthAIdir

Algorithmic Bias

Algorithmic bias occurs when a system produces uneven or harmful performance across groups, settings, or workflows.

technicalPublished 2026/06/11Last verified 2026/07/17

Healthcare compliance context

This definition is for healthcare technology research only and is not medical, legal, civil rights, or compliance advice.

Algorithmic bias occurs when an AI or automation system performs differently across patient groups, sites, specialties, languages, payers, or workflow conditions in a way that creates unfair or unsafe outcomes. Bias can come from training data, measurement choices, missing context, workflow design, or deployment environment.

Healthcare AI buyers should ask how vendors test performance across relevant populations and how issues are monitored after deployment.

Application scenario: In workflow review, this term helps teams map a vendor claim to the care setting, data flow, integration point, user handoff, and oversight step where it applies. Procurement impact: Buyers should evaluate evidence, interoperability effort, security and privacy controls, pricing assumptions, support, and compliance responsibilities before shortlisting or contracting for a tool that depends on this capability.

Sources and review notes

These links support definition-level research and do not establish the regulatory status, safety, or suitability of any product.

NIST SP 1270 treats AI bias as a socio-technical issue and provides a shared foundation for identifying and managing harmful bias, while the NIST AI Risk Management Framework includes fairness with harmful bias managed among the characteristics of trustworthy AI. WHO's ethics and governance guidance for AI in health calls for inclusiveness, equity, accountability, transparency, human autonomy, safety, and ongoing assessment in actual use. These frameworks do not define one universal fairness metric, prove that equal aggregate accuracy means equitable performance, or validate any product or workflow. Teams must define the affected people and decisions, intended use, unacceptable harms, comparison groups, intersectional and small-sample limitations, labels and measurement error, missingness, access and digital-exclusion effects, site and time variation, clinically relevant subgroup metrics with uncertainty, calibration and threshold choices, false-positive and false-negative consequences, human and workflow effects, appeal and override paths, monitoring triggers, remediation ownership, and independent review with affected stakeholders.

FAQs

How can buyers evaluate algorithmic bias?
Ask for subgroup performance, limitations, monitoring plans, escalation procedures, and evidence from settings similar to your own.

Related research

Use related glossary terms and healthcare AI tool profiles to connect terminology checks with vendor due diligence.